MyFinsight
Home
About
Contact
cbih: the income statement
Download
Download image
Merchandise
$61
Clinical Trials
$24,139
Net loss
-$82,645
(-8.31%↓ Y/Y)
Revenues
$24,200
(-86.47%↓ Y/Y)
Total other income
(expense)
-$7,861
(-136.91%↓ Y/Y)
Loss from operations
-$74,784
(23.38%↑ Y/Y)
Change in value of
derivative liabilities
$29,322
Gross profit
$16,057
(-90.58%↓ Y/Y)
Cost of revenues
$8,143
(-2.62%↓ Y/Y)
Interest
$17,368
(642.54%↑ Y/Y)
Total operating
expenses
$90,841
(-66.12%↓ Y/Y)
Amortization of discount
$19,815
Travel
$213
(50.00%↑ Y/Y)
Rent and lease
$11,059
(-39.40%↓ Y/Y)
Officer compensation
$6,000
(0.00%↑ Y/Y)
Professional fees
$7,741
(-78.83%↓ Y/Y)
Contract labor
$42,520
(-7.31%↓ Y/Y)
General and
administrative
$23,308
(-61.97%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Cannabis Bioscience International Holdings, Inc. (CBIH)
Cannabis Bioscience International Holdings, Inc. (CBIH)